Join to View Full Profile
177 West Mill RoadLong Valley, NJ 07853
Dr. Weiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rutgers New Jersey Medical SchoolClass of 1988
Certifications & Licensure
CA State Medical License 1991 - Present
NY State Medical License 1992 - 2026
NJ State Medical License 1992 - 2025
UT State Medical License 2019 - 2022
NE State Medical License 2019 - 2021
IA State Medical License 2019 - 2020
KY State Medical License 2019 - 2020
American Board of Internal Medicine Internal Medicine- Join now to see all
Publications & Presentations
PubMed
- 3 citationsSensing and guiding cell-state transitions by using genetically encoded endoribonuclease-mediated microRNA sensors.Lei Wang, Wenlong Xu, Shun Zhang, Gregory C Gundberg, Christine R Zheng
Nature Biomedical Engineering. 2024-12-01 - 4 citationsSynthetic symmetry breaking and programmable multicellular structure formation.Noreen Wauford, Akshay Patel, Jesse Tordoff, Casper Enghuus, Andrew Jin
Cell Systems. 2023-09-20 - Author Correction: Robust and tunable signal processing in mammalian cells via engineered covalent modification cycles.Ross D Jones, Yili Qian, Katherine Ilia, Benjamin Wang, Michael T Laub
Nature Communications. 2023-08-08
Press Mentions
Rethinking Organoid Technology Through BioengineeringNovember 16th, 2020- Why Am I Always Thirsty? 9 Explanations for Excessive Thirst, According to ExpertsSeptember 27th, 2020
Grant Support
- Immunotherapy via engineered therapeutic programs in tumors using RNAMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population ControlMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- Immunotherapy via engineered therapeutic programs in tumors using RNAMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- Immunotherapy via engineered therapeutic programs in tumors using RNAMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population ControlMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population ControlMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population ControlMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2026
- A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineageMASSACHUSETTS INSTITUTE OF TECHNOLOGY2022–2025
- A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic responseMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2025
- Synthetic gene sensors and effectors to redirect organoid developmentMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2025
- A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic responseMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2025
- A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic responseMASSACHUSETTS INSTITUTE OF TECHNOLOGY2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
